{"id":"W2010881838","doi":"10.3899/jrheum.090128","title":"Comparative Overview of Safety of the Biologics in Rheumatoid Arthritis","year":2009,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nexus Clinical Research (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Etanercept; Adalimumab; Rituximab; Infliximab; Biologic Agents; Anakinra; Lymphoma; Oncology; Internal medicine; Intensive care medicine; Immunology; Dermatology; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001562138,0.0004393808,0.006372576,0.0006168184,0.00005814525,0.000008716953,0.0006338617,0.000324097,0.0005727262],"category_scores_gemma":[0.0003168501,0.0002540592,0.001281592,0.0005884114,0.0005213076,0.00008035431,0.0001687351,0.001054913,0.0000066273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001925786,"about_ca_system_score_gemma":0.001460512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007727234,"about_ca_topic_score_gemma":0.0002019296,"domain_scores_codex":[0.993551,0.001012477,0.004046706,0.0002419477,0.0006800056,0.0004678834],"domain_scores_gemma":[0.9949103,0.0006447486,0.003358128,0.0005174899,0.0004190635,0.0001502537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006198745,0.001331484,0.01212423,0.01138173,0.002329989,0.0001250718,0.00105104,0.000004780229,0.000008607682,0.006753827,0.00996385,0.9543055],"study_design_scores_gemma":[0.003324083,0.001216318,0.0005602813,0.09606633,0.00004955108,0.005435113,0.0003072657,0.000001970878,0.00004415353,0.0004795399,0.8923259,0.0001894654],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002926818,0.994809,0.0000158152,0.0005802693,0.0002963333,0.001074141,0.0001675277,0.000004315541,0.0001258123],"genre_scores_gemma":[0.008688468,0.9905513,0.0006311841,0.00002662397,0.00001001035,0.00001617008,0.00004280567,0.00002157121,0.0000118996],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.954116,"threshold_uncertainty_score":0.9999912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0760866512222513,"score_gpt":0.383231549595562,"score_spread":0.3071448983733107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}